The University Hospital of Düsseldorf is located in the south of Düsseldorf, the state capital of the German state of North Rhine-Westphalia and center of the populous Rhine-Ruhr metropolitan region. It treats approximately 45,000 inpatients and 300,000 outpatients every year in 32 clinics and 34 institutes.

During the past decade, University Hospital Düsseldorf conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 5 clinical trials were completed, i.e. on average, 20.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Düsseldorf" #1 sponsor was "Heinrich-Heine University, Duesseldorf" with 5 trials, followed by "Goethe University" with 3 trials sponsored, "University of Ulm" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "Heidelberg University" with 2 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Düsseldorf" #1 collaborator was "CRISPR Therapeutics" with 2 trials as a collaborator, "Medivation, Inc." with 2 trials as a collaborator, "Aalborg University Hospital" with 1 trials as a collaborator, "Aarhus University Hospital Skejby" with 1 trials as a collaborator and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Düsseldorf" are "Acute Myeloid Leukemia" (3 trials), "BRCA 1 Gene Mutation" (2 trials), "BRCA 2 Gene Mutation" (2 trials), "Breast Neoplasms" (2 trials) and "Endothelial NO-synthase" (2 trials). Many other conditions were trialed in "University Hospital Düsseldorf" in a lesser frequency.

Most popular intervention types in "University Hospital Düsseldorf" are "Drug" (26 trials), "Device" (10 trials), "Other" (4 trials), "Procedure" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "CTX001" (2 trials), "talazoparib" (2 trials), "5-Fluorouracil" (1 trials) and "Afinitor" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Düsseldorf" are 50 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University Hospital Düsseldorf". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in University Hospital Düsseldorf, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Düsseldorf, 6 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".